Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas: a rare adverse effect. BMJ Case Rep 2017 Jun 18;2017

Date

06/21/2017

Pubmed ID

28630242

Pubmed Central ID

PMC5534705

DOI

10.1136/bcr-2017-219883

Scopus ID

2-s2.0-85020923415 (requires institutional sign-in at Scopus site)   2 Citations

Abstract

A 53-year-old man with a history of Crohn's disease on infliximab, presented with several weeks of cough and dyspnoea. He had a right-sided pleural effusion, found to be exudative with lymphocytic predominance. He underwent right-sided video-assisted thoracic surgery (VATS) with biopsies and pleurodesis. Histopathology showed pleural-based non-caseating granulomas with unremarkable lung parenchyma. Cultures were only positive for Propionibacterium acnes 8 months later, he was found to have a left-sided exudative, lymphocytic predominant pleural effusion. Left-sided VATS and biopsies again showed pleural-based non-caseating granulomas with normal lung parenchyma. Having ruled out an active infection and malignant lesions, we diagnosed infliximab-induced pleural granulomas. Infliximab was stopped. The patient continues to do well at 6 years of follow-up. We believe this is the first report of tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas. P. acnes and cytokine imbalance might be responsible for the pathogenesis of TNF inhibitor-induced granulomas.

Author List

Ali MS, Franco R, Dhotre D, Rao N

Author

Rose Franco MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Cough
Crohn Disease
Dyspnea
Gastrointestinal Agents
Gram-Positive Bacterial Infections
Granuloma
Humans
Infliximab
Male
Middle Aged
Pleural Effusion
Pleurodesis
Propionibacterium acnes
Thoracic Surgery, Video-Assisted
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha